comparative efficacy of shatapushpa taila nasya & shatapushpa churna in artavakshaya

Dr Lalita Prajapat0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年7月25日

试验速览

暂无简介。

•Age group 18- 40 yrs.
•Interval between two menstrual cycles is greater than 35 days. (for the last 6 months approximately)
•The duration of menstrual flow is 2 days or less. .(for the last 6 months approximately)
•The quantity of menses is less than 20 ml.
•Poly Cystic Ovarian Disease (PCOD) with the symptom of oligomenorrhea and hypomenorrhea.

•Patients below the age of 18 years and above the age of 40 years.
•Positive history of venereal diseases (HIV, HBsAg, Anti HCV, VDRL, HPV, Genital herpes, etc.)
•Pregnant women, lactating mothers.
•Poly Cystic Ovarian Disease (PCOD) with menorrhagia.
•Patient having organic pathology of uterus & adnexa like cervical carcinoma or any malignant growth.
•Patients will not give consent to participate in the study.
•Patients using oral contraceptive pills.
•Patients who cannot attend follow-up regularly. Who is participating in another study.
•Women suffering from Nasal polyp, D.N.S.(Deviated nasal septum), Rhinitis. Nasal tumor, and history of nasal surgery previous.

发起方

Dr Lalita Prajapat